Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06353074
Status:
COMPLETED
Last Update Posted:
2024-04-08
First Post:
2023-12-26
Brief Title:
Uterine Preservation With Acars Atony Suture for Postpartum Uterine Hemorrhage
Sponsor:
Necmettin Erbakan University
Organization:
Necmettin Erbakan University
Study Overview
Official Title:
Uterine Preservation With Acars Atony Suture for Postpartum Uterine Atony
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is aimed to show effectiveness of a new suture technique to stop postpartum uterine bleeding due to uterine atony
Detailed Description:
A retrospective study of all women received Acars uterine compressive atony suture between January 2021-November 2023 at a single tertiary hospital with approximately 4000 deliveries per year was performed The local protocol for PPH due to uterine atony is uterine manual compression 20 IU of intravenous oxytocin in 500 cc of normal saline at 500 cch 800 µg of misoprostol inserted per rectal If additional treatment is needed carbetocin 100mcg in 100 cc of normal saline or tranexamic acid in different posologies are used
If uterine atony persists intrauterine balloon tamponade or uterine compressive sutures were applied at the discretion of the physician and according to mode of delivery When uterine compressive suture was performed original Acars atony suture was applied
If uterine atony persists intrauterine balloon tamponade or uterine compressive sutures were applied at the discretion of the physician and according to mode of delivery When uterine compressive suture was performed original Acars atony suture was applied
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None